menu ☰
menu ˟

Trial Scorecard: BIOCRT

08 Feb 2016
Researchers assessed cystatin C as a predictor for adverse outcomes in patients with HF needing cardiac resynchronization therapy. ...

Click here to view the full article which appeared in Cardiology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.